Stock Earnings

Question 1

Bionik Laboratories Corpの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Bionik Laboratories Corpの総資産は$3で、純lossは$-4です。

Question 2

BNKLの主要な財務比率は何ですか？

Accepted Answer

Bionik Laboratories Corpの流動比率は0.6、純利益率は-400、1株当たり売上高は$0.14です。

Question 3

Bionik Laboratories Corpの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Bionik Laboratories Corp data is not available.

Question 4

Bionik Laboratories Corpは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Bionik Laboratories Corpの純lossは$-4です。

Question 5

Bionik Laboratories Corpに負債はありますか？

Accepted Answer

yes、Bionik Laboratories Corpの負債は5です。

Question 6

Bionik Laboratories Corpの発行済株式数は何株ですか？

Accepted Answer

Bionik Laboratories Corpの総発行済株式数は6.87株です。

Breakdown	TTM	03/31/2023	03/31/2022	03/31/2021	03/31/2020	03/31/2019
Revenue	1	1	1	1	2	3
Revenue Growth (YoY)	0%	0%	0%	-50%	-33%	--
Cost of Revenue	0	0	0	0	0	1
Gross Profit	0	0	0	0	1	1
Selling, General & Admin	4	4	4	5	8	7
Research & Development	0	0	0	1	3	3
Operating Expenses	5	5	5	7	12	11
Other Non Operating Income (Expenses)	0	0	0	0	0	1
Pretax Income	-4	-4	-10	-13	-25	-10
Income Tax Expense	--	--	--	--	--	--
Net Income	-4	-4	-10	-13	-25	-10
Net Income Growth	-60%	-60%	-23%	-48%	150%	-28.99%
Shares Outstanding (Diluted)	6.97	6.9	5.84	5.12	4.45	2.36
Shares Change (YoY)	18%	18%	14%	15%	89%	250.99%
EPS (Diluted)	-0.71	-0.71	-1.78	-2.65	-5.61	-4.46
EPS Growth	-59%	-60%	-33%	-53%	26%	-79%
Free Cash Flow	-3	-3	-4	-4	-9	-9
Free Cash Flow Per Share	-0.43	-0.43	-0.68	-0.77	-2.01	-3.8
Gross Margin	0%	0%	0%	0%	50%	33.33%
Operating Margin	-400%	-400%	-400%	-600%	-550%	-300%
Profit Margin	-400%	-400%	-1,000%	-1,300%	-1,250%	-333.33%
Free Cash Flow Margin	-300%	-300%	-400%	-400%	-450%	-300%
EBITDA	-4	-4	-4	-6	-11	-9
EBITDA Margin	-400%	-400%	-400%	-600%	-550%	-300%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-4	-4	-4	-6	-11	-9
EBIT Margin	-400%	-400%	-400%	-600%	-550%	-300%
Effective Tax Rate	--	--	--	--	--	--

Bionik Laboratories Corp (BNKL) Price